Arm Exercise Capacity, Muscle Strength and Activities of Daily Living in Patients with Fibromyalgia Syndrome

November 6, 2024 updated by: Merve Firat, Kirsehir Ahi Evran Universitesi

Comparison of Arm Exercise Capacity, Muscle Strength and Daily Living Activities of Patients with Fibromyalgia Syndrome and Healthy Controls

The aim of this study is to compare the upper extremity exercise capacity, muscle strength and activities of daily living of patients with fibromyalgia syndrome and healthy individuals.

Study Overview

Status

Not yet recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Patients with fibromyalgia syndrome and healthy individuals will be included in the study.

Description

Inclusion Criteria-fibromyalgia syndrome:

  • Being diagnosed with fibromyalgia syndrome
  • Being aged 18-65
  • Stable use of medication for at least 3 months or longer
  • Volunteering to participate in the study

Exclusion Criteria-fibromyalgia syndrome:

  • Having comorbidities that may affect physical functions
  • Failure to cooperate with tests to be performed
  • Presence of exercise test contraindication

Inclusion Criteria-healthy control:

  • Being aged 18-65
  • Volunteering to participate in the study

Exclusion Criteria-healthy control:

  • Having a chronic or systemic disease
  • Failure to cooperate with tests to be performed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy controls
Fibromyalgia syndrome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Upper extremity exercise capacity
Time Frame: 1st day
This will be evaluated with arm ergometer test.
1st day
Muscle strength
Time Frame: 1st day
Hand grip strength will be measured using a hand grip dynamometer.
1st day
Muscle endurance
Time Frame: 1st day
30 second push-up test will be used, and total number will be recorded.
1st day
Activities of daily living
Time Frame: 1st day
It will be evaluated with the Glittre Activities of Daily Living test, and total time will be recorded.
1st day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kirsehir Ahi Evran Universitesi

Investigators

  • Study Chair: Basak Kavalci Kol, Kirşehir Ahi Evran University
  • Study Chair: Figen Tuncay, Kirşehir Ahi Evran University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 1, 2024

Primary Completion (Estimated)

May 1, 2025

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

November 6, 2024

First Submitted That Met QC Criteria

November 6, 2024

First Posted (Estimated)

November 7, 2024

Study Record Updates

Last Update Posted (Estimated)

November 7, 2024

Last Update Submitted That Met QC Criteria

November 6, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-13/115

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe